Immuneel Therapeutics: Funding, Investors & Team (Oct 2026)
Immuneel Therapeutics is a clinical-stage biotechnology company that develops cell and gene therapies focused on cancer treatment. The company works primarily on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a form of personalized immunotherapy where a patient’s immune cells are modified to target and destroy cancer cells more effectively. Its platform integrates research, clinical development, and manufacturing capabilities to support the delivery of advanced cancer therapies. The company concentrates on making these therapies more accessible and cost-efficient, particularly in markets where such treatments are limited or expensive. It develops end-to-end capabilities that include cell processing, vector manufacturing, and clinical-grade production systems for immunotherapy products. This infrastructure supports both ongoing clinical trials and future commercialization of CAR-T therapies for blood cancers such as lymphomas and leukemias.
Immuneel Therapeutics has raised $10.5M across 1 funding round on record, the most recent a Series B of $10.5M announced in Jun 2026.
That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Immuneel Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Immuneel Therapeutics Funding Rounds
Immuneel Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Immuneel Therapeutics Funding Compared to Other Health Care Startups
Immuneel Therapeutics' latest round of $10.5M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immuneel Therapeutics in Health Care and Bengaluru
Companies Similar to Immuneel Therapeutics
betterhood is an Indian wellness brand providing products for pain relief, posture support, and active living.
InstaAstro offers individual Astrology consultations, along with Daily Activity Tracks & Content, to assist…
Lissun is a comprehensive mental health and well-being platform that aims to offer mental health remedies to…
Fibroheal Woundcare Pvt Ltd focuses on leveraging silk proteins to create biomedical applications for…
Mykare Health is constructing the largest affordable and reliable hospital network in India. So far, Mykare…
SuperLiving is a lifestyle-tech platform designed for Bharat that aims to make everyday life more attentive…
QubeHealth is a healthcare payments company. Integrating a massive ‘payments infrastructure’ in India,…
MediElaj is a digital healthcare platform designed to provide accessible medical assistance through a mobile…
SS Innovations to improve gold standard surgical procedures through the union of great skill, patient care…
Pulse focuses on low and mid-complexity medical equipment and consumables categories where India has strong…
Gut Clinic operates specialised outpatient centres focused on gastroenterology, liver, and metabolic health.
Immuneel Therapeutics Funding FAQs
What does Immuneel Therapeutics do?
Immuneel Therapeutics is a clinical-stage biotechnology company that develops cell and gene therapies focused on cancer treatment. The company works primarily on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a form of personalized immunotherapy where a patient’s immune cells are modified to target and destroy cancer cells more effectively. Its platform integrates research, clinical development, and manufacturing capabilities to support the delivery of advanced cancer therapies. The company concentrates on making these therapies more accessible and cost-efficient, particularly in markets where such treatments are limited or expensive. It develops end-to-end capabilities that include cell processing, vector manufacturing, and clinical-grade production systems for immunotherapy products. This infrastructure supports both ongoing clinical trials and future commercialization of CAR-T therapies for blood cancers such as lymphomas and leukemias.
How much funding has Immuneel Therapeutics raised?
Immuneel Therapeutics has raised $10.5M across 1 round on record. The most recent is a Series B of $10.5M announced in Jun 2026.
When did Immuneel Therapeutics last raise funding?
Immuneel Therapeutics' most recent funding round on record is a Series B of $10.5M, announced in Jun 2026.
Who founded Immuneel Therapeutics?
FundedIQ lists Amit Mookim (Founder) at Immuneel Therapeutics.
Where is Immuneel Therapeutics headquartered?
Immuneel Therapeutics is based in Bengaluru, Karnataka, India.
How many employees does Immuneel Therapeutics have?
Immuneel Therapeutics is in the 51-100 employee band.
How does Immuneel Therapeutics' funding compare to other Health Care startups?
Immuneel Therapeutics' latest round of $10.5M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,657 tracked companies over the last two years.
About FundedIQ's Immuneel Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immuneel Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.